NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH ...

LOS ANGELES, CA / ACCESS Newswire / April 28, 2025 / In the realm of spinal disorders, few conditions are as elusive - and misunderstood - as Thoracic Myelopathy. This severely underdiagnosed ...

LOS ANGELES, CA / ACCESS Newswire / April 28, 2025 / In the heart of Beverly Hills, Dr. Hooman Melamed is redefining spine surgery with cutting-edge motion-sparing technologies - offering renewed hope ...

Worcester-based company recognized for its consistent, people-first approach to transportation WORCESTER, MA / ACCESS Newswire / April 28, 2025 / Instant Transportation, a trusted transportation ...

WALTHAM, MASSACHUSETTS / ACCESS Newswire / April 28, 2025 / Data4Cure, Inc., a leading biomedical data-to-knowledge company, today announced the presentation of two new research abstracts at the 2025 ...

HACKENSACK, NJ / ACCESS Newswire / April 28, 2025 / Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in ...

ATLANTA, GEORGIA / ACCESS Newswire / April 28, 2025 / Leading health technology company MentalHealth.com is pleased to announce its acquisition of online mental health resource and clinical guidelines ...

The global CRBSI treatment market is on a significant growth trajectory, projected to experience a compound annual growth rate (CAGR) of 5.4% between 2025 and 2035. This growth is being propelled by ...

PersonnelSecarna Pharmaceuticals adds leading expert to Scientific Advisory Board with appointment of Prof. Dr. Vignali 28.04.2025 / 14:30 CET/CESTThe issuer is solely responsible for the content of ...

The global non-small cell lung carcinoma market is poised for significant expansion over the next decade, according to new industry projections. Valued at USD 8.25 billion in 2023, the NSCLC market is ...

The global primary sclerosing cholangitis (PSC) market is on an impressive growth trajectory, with forecasts estimating a market valuation of USD 314.26 million by 2033. This robust expansion is ...

The global checkpoint inhibitor refractory cancer market is experiencing significant growth, with an expected valuation of USD 38.69 billion in 2023. This expansion is fueled by the rising health ...